Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-10
2000-12-19
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 514348, 514349, 514350, 514352, 514423, 514424, 514425, 514426, 514432, 514434, 514444, 514445, 514446, 514447, 514472, 514473, 514510, 514546, 514569, 514657, 514708, 514709, 514712, 514717, 514719, A61K 31395, A61K 3144
Patent
active
061628158
ABSTRACT:
Novel pharmaceutically/cosmetically-active polycyclic aromatic compounds having the structural formula (I): ##STR1## wherein Ar is a radical having one of the formulae (a)-(e): ##STR2## which are useful for the treatment of a wide variety of disease states, whether human or veterinary, for example dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders, as well as for the treatment of mammalian skin and hair conditions/disorders are provided. In particular, based on their RXR-agonist activity, these compounds may be used to treat noninsulin-dependent diabetes mellitus (NIDDM) and obesity.
Centre International de Recherches Dermatologiques Galderma
Raymond Richard L.
LandOfFree
RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmet does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmet will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-271595